Trump's Drug Pricing Order Casts Shadow on Roche's $50 Billion U.S. Investment
Published on: May 14, 2025, 7:42 p.m. | Source: Devdiscourse
President Donald Trump's executive order mandates drugmakers to lower prices to match those in affluent nations, threatening Roche's $50 billion U.S. investment plan. While the policy may be tough to implement, Roche assures its 2025 business remains unaffected and continues its dialogue with the administration and Congress.
